Novozymes to merge with Danish bioscience group
Denmark’s Novozymes and compatriot bioscience firm Chr. Hansen are planning a merger to form a leading player within bioscience products globally, the companies inform in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novozymes overwhelmed by bioenergy's success
For subscribers